Vaccine effectiveness of the first dose of ChAdOx1 nCoV-19 and BNT162b2 against SARS-CoV-2 infection in residents of long-term care facilities in England (VIVALDI): a prospective cohort study

Supporters

Support the authors with ResearchCoin

Tip RSC

Journal

The Lancet Infectious Diseases

Topics

Medicine

Internal Medicine

Pediatrics

Emergency Medicine

Infectious Diseases

Show all topics

DOI

10.1016/s1473-3099(21)00289-9

License

CC-BY-NC-ND

Other Formats

PDF